Psychedelics
Unlocking the Potential of Psychedelics for Postpartum Depression
Greg Mayes, J.D.
Reunion Neuroscience
PAO-03-25-CL-05Mar 31, 2025
FDA Approval
FDA Approves First Treatment for Postpartum Depression
U.S. Food & Drug Administration
PR-M03-19-NI-064Mar 22, 2019
FDA Acceptance
Sage Therapeutics Announces FDA Acceptance of NDA Filing and Grant of Priority Review for Brexanolone IV in the Treatment of Postpartum Depression
Sage Therapeutics
PR-M06-18-NI-007Jun 04, 2018